Results: Exosomes can inhibit the expression of fibrosis-related factors a-SMA and COL11 in LX-2 cells
Pharmacokinetics Routes: IV, IM, transdermal patch, transmucosal (lozenge, buccal, nasal spray) Onset: Rapid (within minutes when given IV) Duration: Short (3060 minutes IV), longer with transdermal patch Metabolism: Hepatic (CYP3A4 enzyme) Elimination: Renal (mostly metabolites) Clinical Uses Pain management: Severe, chronic pain (especially cancer pain) Anesthesia: Induction and maintenance of anesthesia, adjunct to general anesthesia Procedural sedation: In ICU or emergency settings Postoperative pain (controlled settings only) Adverse Effects Respiratory depression (most serious) Sedation, dizziness Nausea, vomiting, constipation Bradycardia, hypotension Tolerance and dependence with prolonged use Contraindications Hypersensitivity to fentanyl Respiratory depression or severe asthma Paralytic ileus (for transdermal use) Precautions Use with caution in elderly, hepatic impairment, or patients with COPD
A long-term deficiency can cause irreversible nerve damage, showing up as tingling, numbness, or even problems with balance
Heres a typical schedule of Compounded* Liraglutide with B12 dose adjustments: Week 1: 0.6 mg (0.2 ml) 20 units Week 2: 1.2 mg (0.4 ml) 40 units Week 3: 1.8 mg (0.6 ml) 60 units Week 4: 2.4 mg (0.8 ml) 80 units Week 5 and beyond: 3.0 mg (1.0 ml) 100 units Your dose adjustments from week five may vary depending on your unique needs, and Levity will guide you through the entire journey to ensure your dose is working effectively at every step
